This is the authors' abstract. We don't add key points for this paper.
CuO nanoparticles were produced utilizing Typha domingensis leaf extract as a reducing agent and stabilizer by an eco‐friendly method. The distinctive absorption peak at 320 nm for CuO NPs in the UV–Vis spectrum confirmed their formation, and the band gap was determined at 2.77 eV, exhibiting semiconductor properties. FTIR spectra revealed a peak at 539 cm −1 for Cu‐O vibration, corroborating the synthesis of CuO NPs, and also identified the existence of phytochemicals, which facilitated the reduction of copper ions. Spherical nanoparticles were found in the SEM image with its regularity. The XRD picture indicated peaks corresponding to CuO NPs with JCPDS No: 80‐1916, and the particles exhibited a pure and crystalline nature with a mean size of 17.78 nm. The biological activity was tested through antioxidant, antifungal, and antibacterial assays. Using DPPH, the antioxidant activity showed significant scavenging, yielding an IC 50 of 35.12 μg/mL. The effectiveness of CuO NPs against microbial organisms was evaluated against pathogenic fungi ( Colletotrichum sp. and Fusarium sp.) and gram‐negative bacterial strains ( Salmonella sp. and Coliform spp.). The findings demonstrate that CuO NPs have the most significant antimicrobial efficacy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Setu et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: